Assignee
IDENIX PHARMACEUTICALS INC
US·53 granted patents·22 pending applications·3,101 citations·filing 1999–2015
Top patents by PatentIndex Score
75 records- 0199US7608600B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Oct 27, 2009·181 cites·85 claims
- 0299US7608597B2Methods and compositions for treating hepatitis C virusIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Oct 27, 2009·184 cites·33 claims
- 0399US7365057B2Modified 2′ and 3′-nucleoside prodrugs for treating Flavivridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Apr 29, 2008·118 cites·52 claims
- 0499US6914054B2Methods and compositions for treating hepatitis C virusIDENIX PHARMACEUTICALS INC·Filed 2001·Granted Jul 5, 2005·252 cites·27 claims
- 0599US6812219B2Methods and compositions for treating flaviviruses and pestivirusesIDENIX PHARMACEUTICALS INC·Filed 2001·Granted Nov 2, 2004·211 cites·32 claims
- 0698US9211300B24′-fluoro nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Dec 15, 2015·66 cites·23 claims
- 0798US8507460B2Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infectionsIDENIX PHARMACEUTICALS INC·Filed 2012·Granted Aug 13, 2013·67 cites·20 claims
- 0898US8343937B2Methods and compositions for treating flaviviruses and pestivirusesIDENIX PHARMACEUTICALS INC·Filed 2006·Granted Jan 1, 2013·52 cites·10 claims
- 0998US7635689B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Dec 22, 2009·120 cites·29 claims
- 1098US7582618B22′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2006·Granted Sep 1, 2009·81 cites·36 claims
- 1198US7547704B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Jun 16, 2009·84 cites·40 claims
- 1298US6566344B1β-L-2′-deoxy-nucleosides for the treatment of hepatitis BIDENIX PHARMACEUTICALS INC·Filed 2001·Granted May 20, 2003·122 cites·105 claims
- 1397US9187515B22′,4′-fluoro nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Nov 17, 2015·51 cites·16 claims
- 1497US7951789B2Compounds and pharmaceutical compositions for the treatment of viral infectionsIDENIX PHARMACEUTICALS INC·Filed 2007·Granted May 31, 2011·92 cites·10 claims
- 1597US7902202B2Compounds and pharmaceutical compositions for the treatment of viral infectionsIDENIX PHARMACEUTICALS INC·Filed 2008·Granted Mar 8, 2011·80 cites·29 claims
- 1697US7625875B22′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Dec 1, 2009·86 cites·44 claims
- 1797US7384924B2Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Jun 10, 2008·77 cites·46 claims
- 1897US6875751B23′-prodrugs of 2′-deoxy-β-L-nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2001·Granted Apr 5, 2005·131 cites·25 claims
- 1997US6787526B1Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2002·Granted Sep 7, 2004·93 cites·25 claims
- 2097US6569837B1β-L-2′-deoxy pyrimidine nucleosides for the treatment of hepatitis BIDENIX PHARMACEUTICALS INC·Filed 2001·Granted May 27, 2003·98 cites·49 claims
- 2196US9309275B23′-deoxy nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Apr 12, 2016·28 cites·24 claims
- 2296US9109001B23′,5′-cyclic phosphoramidate prodrugs for HCV infectionIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Aug 18, 2015·60 cites·28 claims
- 2396US7662798B22′ and 3′-nucleoside prodrugs for treating Flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Feb 16, 2010·77 cites·20 claims
- 2496US7456155B22′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Nov 25, 2008·88 cites·39 claims
- 2595US8362068B25,5-fused arylene or heteroarylene hepatitis C virus inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2010·Granted Jan 29, 2013·66 cites·53 claims
- 2695US6596700B2Methods of treating hepatitis delta virus infection with β-L-2'-deoxy-nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2001·Granted Jul 22, 2003·61 cites·57 claims
- 2794US9296778B23′,5′-cyclic phosphate prodrugs for HCV infectionIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Mar 29, 2016·37 cites·21 claims
- 2894US7932240B2Phosphadiazine HCV polymerase inhibitors IVIDENIX PHARMACEUTICALS INC·Filed 2008·Granted Apr 26, 2011·39 cites·61 claims
- 2994US7585851B23′-prodrugs of 2′-deoxy-β-L-nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2004·Granted Sep 8, 2009·69 cites·112 claims
- 3093US9339541B2Thiophosphate nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2014·Granted May 17, 2016·36 cites·20 claims
- 3192US7824851B22′-branched nucleosides and Flaviviridae mutationIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Nov 2, 2010·75 cites·27 claims
- 3291US7781576B2Process for preparing a synthetic intermediate for preparation of branched nucleosidesIDENIX PHARMACEUTICALS INC·Filed 2006·Granted Aug 24, 2010·29 cites·38 claims
- 3390US7534809B2Phospho-indoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2005·Granted May 19, 2009·16 cites·82 claims
- 3489US7304043B2β-L-2′-deoxy-nucleosides for the treatment of hepatitis BIDENIX PHARMACEUTICALS INC·Filed 2005·Granted Dec 4, 2007·8 cites·24 claims
- 3588US9249173B2Compounds and pharmaceutical compositions for the treatment of viral infectionsIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·8 cites·23 claims
- 3688US8481748B2Phosphinate ruthenium complexesIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Jul 9, 2013·4 cites·42 claims
- 3787US9186369B2Purine nucleoside analogues for treating flaviviridae including hepatitis CIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Nov 17, 2015·8 cites·28 claims
- 3887US8377962B2Macrocyclic serine protease inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2010·Granted Feb 19, 2013·14 cites·93 claims
- 3987US7598373B2Process for the production of 2-C-methyl-D-ribonolactoneIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Oct 6, 2009·43 cites·30 claims
- 4087US6710068B2Phenylindoles for the treatment of HIVIDENIX PHARMACEUTICALS INC·Filed 2002·Granted Mar 23, 2004·25 cites·14 claims
- 4184US9187496B25,5-fused arylene or heteroarylene hepatitis C virus inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2012·Granted Nov 17, 2015·8 cites·45 claims
- 4284US8993595B2Macrocyclic serine protease inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Mar 31, 2015·8 cites·96 claims
- 4384US7795238B2β-L-2′-deoxy-nucleosides for the treatment of hepatitis BIDENIX PHARMACEUTICALS INC·Filed 2007·Granted Sep 14, 2010·3 cites·18 claims
- 4483US8765966B2Phosphinate ruthenium complexesIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Jul 1, 2014·2 cites·42 claims
- 4582US7186700B2β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapiesIDENIX PHARMACEUTICALS INC·Filed 2003·Granted Mar 6, 2007·18 cites·24 claims
- 4680US2011195922A9Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis BIDENIX PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4779US7960428B2Enantiomerically pure phosphoindoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2007·Granted Jun 14, 2011·3 cites·42 claims
- 4876US8410313B2Phosphinate ruthenium complexesIDENIX PHARMACEUTICALS INC·Filed 2012·Granted Apr 2, 2013·1 cites·20 claims
- 4976US8044091B2Phospho-indoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2008·Granted Oct 25, 2011·2 cites·25 claims
- 5075US2014213540A1Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infectionsIDENIX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →